A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease

December 18, 2009 updated by: Catholic University of the Sacred Heart

Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease: Insights From a Meta-analysis

A meta-analysis to compare outcomes of drug eluting stents (DES) versus bare metal stent (BMS) in saphenous vein graft (SVG) disease.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

To compare outcomes (death, myocardial infarction, target vessel revascularization) of drug eluting stent versus bare metal stent in saphenous vein graft disease.

Study Type

Observational

Enrollment (Actual)

5806

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients with CABG disease

Description

Inclusion Criteria:

  • CABG disease
  • randomized studies
  • not randomized studies

Exclusion Criteria:

  • studies reporting composite and not single endpoints, duplicate reporting

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
cabg disease
pts with saphenous vein graft disease
Device: drug eluting stent
pts with cabg disease treated with drug eluting stent
Other Names:
  • des
Device: bare metal stent
pts with cabg disease treated with bare metal stent
Other Names:
  • bms

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
death
Time Frame: years depending from studies retrieved
years depending from studies retrieved

Secondary Outcome Measures

Outcome Measure
Time Frame
myocardial infarction
Time Frame: years depending from study retrieved
years depending from study retrieved
target vessel revascularization
Time Frame: years depending from study retrieved
years depending from study retrieved

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Catholic University of the Sacred Heart

Investigators

  • Principal Investigator: ALESSANDRO LUPI, MD, Ospedale Maggiore Novara
  • Principal Investigator: ELIANO NAVARESE, MD, Catholic University Of Sacred Heart

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2009

Primary Completion (ACTUAL)

December 1, 2009

Study Completion (ACTUAL)

December 1, 2009

Study Registration Dates

First Submitted

December 7, 2009

First Submitted That Met QC Criteria

December 18, 2009

First Posted (ESTIMATE)

December 21, 2009

Study Record Updates

Last Update Posted (ESTIMATE)

December 21, 2009

Last Update Submitted That Met QC Criteria

December 18, 2009

Last Verified

December 1, 2009

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • N28LBCF80-07

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Saphenous Vein Graft Disease

Clinical Trials on drug eluting stent

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe